Pharmacologic, clinico-pharmacologic and clinical effects of Libexin.
D000818:Animals; D000996:Antitussive Agents / Q000008:administration & dosage / Q000627:therapeutic use* / Q000633:toxicity; D003061:Codeine / Q000008:administration & dosage / Q000627:therapeutic use; D003371:Cough / Q000188:drug therapy; D006168:Guinea Pigs; D006801:Humans; D007928:Lethal Dose 50; D051379:Mice; D010069:Oxadiazoles / Q000008:administration & dosage / Q000627:therapeutic use / Q000633:toxicity; D010880:Piperidines / Q000627:therapeutic use* / Q000633:toxicity; D011817:Rabbits; D051381:Rats
D000996:Antitussive Agents; D010069:Oxadiazoles; D010880:Piperidines; D003061:Codeine